Lotte Biologics
Boston, United States· Est.
A full‑service global CDMO delivering biologics development, manufacturing, and ADC conjugation.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A full‑service global CDMO delivering biologics development, manufacturing, and ADC conjugation.
Technology Platform
Integrated cell‑culture bioprocessing platform with cGMP manufacturing, analytical testing, and antibody‑drug conjugation capabilities.
Opportunities
Expansion of manufacturing capacity in South Korea and growing demand for ADC services present significant revenue upside.
Risk Factors
Intense competition from established global CDMOs and regulatory compliance challenges could constrain market share.
Competitive Landscape
Competes with large CDMOs such as Lonza, Samsung Biologics, and Thermo Fisher, differentiating through integrated development‑to‑manufacturing services and strong backing from the Lotte Group.